Browse Title Index


 
Issue Title
 
Vol 11, No 4 (2015): July/August 12-Month safety and effectiveness of once-daily hydrocodone Abstract
Warren Wen, PhD, Louise Taber, MD, Shau Yu Lynch, PhD, Ellie He, PhD, Steven Ripa, MD
 
Vol 10, No 4 (2014): July/August 2014 INTERNATIONAL CONFERENCE ON OPIOIDS Posters presented June 8-10, 2014 Abstract
JOM Editors
 
Vol 12, No 6 (2016): November/December 2017 International Conference on Opioids Announcement Abstract
2017 ICOO Conference Committee
 
Vol 13, No 1 (2017): January/February 2017 International Conference on Opioids Brochure and Schedule Details
Conference Committee
 
Vol 12, No 6 (2016): November/December A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation Abstract
Lynn Webster, MD, Raj Tummala, MD, MBA, MS, Ulysses Diva, PhD, Jaakko Lappalainen, MD, PhD
 
Vol 14, No 3 (2018): May/June A case for opioid education and training for medical students, residents, and allied health staff: response to “educational intervention for physicians to address the risk of opioid abuse” Abstract
Anees Bahji, BScH, MD, Daenis Camiré, BScN, RN, MD
 
Vol 10, No 3 (2014): May/June A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center Abstract
Yatan Pal Singh Balhara, MD, DNB, MNAMS
 
Vol 8, No 2 (2012): March/April A comparative study on the effects of intrathecal morphine added to levobupivacaine for spinal anesthesia Abstract
Hakki Unlugenc, MD, Murat Gunduz, MD, Baris Guzel, MD, Geylan Isik, MD
 
Vol 7, No 5 (2011): September/October A comparison of methods of administering the Opioid Risk Tool Abstract
Ted Jones, PhD, Steven D. Passik, PhD
 
Vol 1, No 5 (2005): November/December A comparison of oral and implant naltrexone outcomes at 12 months Abstract   PDF
Ross Colquhoun, BPsych(Hons), Donald Y-K. Tan, MBBS, Samantha Hull, BPsych(Hons)
 
Vol 3, No 2 (2007): March/April A comparison of oral midazolam, oral tramadol, and intranasal sufentanil premedication in pediatric patients Abstract   PDF
Fatma Bayrak, MD, Isil Gunday, MD, Dilek Memis, MD, Alparslan Turan, MD
 
Vol 2, No 2 (2006): March/April A comparison of patient-controlled epidural pethidine vs. nurse-administered epidural pethidine for analgesia after caesarean section Abstract   PDF
Yvonne Lim, MMed, Sally Wilson, Steven Katz, MD
 
Vol 1, No 1 (2005): March/April A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons Abstract   PDF
Diane E. Arnold-Reed, PhD, Gary K. Hulse, PhD
 
Vol 13, No 2 (2017): March/April A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications Abstract
Corey J. Hayes, PharmD, MPH, Jacob T. Painter, PharmD, MBA, PhD
 
Vol 2, No 2 (2006): March/April A descriptive case series: Oral transmucosal fentanyl use in patients with noncancerous pain Abstract   PDF
Anthony H. Guarino, MD, Jennifer Myers, RN, MSN, ANP, Martha E. Cornell, RN, BSN
 
Vol 7, No 1 (2011): January/February A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts Abstract
Kushal Jain, MD, Raka Jain, PhD, FRSC Chem, Anju Dhawan, MD
 
Vol 6, No 5 (2010): September/October A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain Abstract
Lynn Webster, MD, Patricia Richards, MD, PhD, Warren Stern, PhD, Robin Kelen, RN, BA, CNN
 
Vol 12, No 6 (2016): November/December A more balanced approach to opioid use and management is also needed in end-of-life care Abstract
Sydney Morss Dy, MD, MSc, Cynda Hylton Rushton, PhD, RN, FAAN
 
Vol 10, No 6 (2014): November/December A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain Abstract
Samir Arora, MD, Beatrice Setnik, PhD, Michael Drass, MD, John D. Hudson, MD, Ray Clemmer, MS, Paul Meisner, PharmD, Glenn C. Pixton, MS, Veeraindar Goli, MD, Kenneth W. Sommerville, MD
 
Vol 10, No 5 (2014): September/October A multifactorial intervention for hospital opioid management Abstract
Mehmet Akce, MD, Anupam Suneja, MD, Cheryl Genord, RPh, Bonita Singal, MD, PhD, John A. Hopper, MD
 
Vol 3, No 4 (2007): July/August A new type of harm reduction: Creating an arteriovenous fistula for a compulsively injecting opiate user Abstract
Colin Brewer, MB, Mohammed Sobeh, FRCS
 
Vol 4, No 5 (2008): September/October A PARADOXICAL, NOVEL APPROACH: COMBINING MINUTE NALOXONE WITH MORPHINE INTRATHECAL INFUSION Abstract
Xiulu Ruan, MD
 
Vol 2, No 6 (2006): November/December A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: Overview and applications Abstract   PDF
Kevin T. Bain, PharmD, BCPS, CGP, FASCP
 
Vol 11, No 5 (2015): September/October A pharmacokinetic evaluation of single and multiple doses of extended-release hydrocodone bitartrate in subjects experiencing surgical or osteoarthritic pain Abstract
Cynthia Y. Robinson, PhD, Christopher M. Rubino, PharmD, Stephen J. Farr, PhD
 
Vol 12, No 1 (2016): January/February A phase I study of d-methadone in patients with chronic pain Abstract
Natalie Moryl, MD, Cristina Tamasdan, MD, Dana Tarcatu, MD, Howard T. Thaler, PhD, Denise Correa, PhD, Richard Steingart, MD, FACC, Richard Payne, MD, Eugenie Obbens, MD, PhD
 
1 - 25 of 729 Items 1 2 3 4 5 6 7 8 9 10 > >> 
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR